Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation
ConditionOvarian Stimulation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-39
SponsorART Fertility Clinics LLC
About this trial
This study examines if monitoring serum Follicle Stimulation Hormone (FSH) levels can predict oocyte yield and progesterone levels, considering factors like age, baseline FSH, Antral Mullerian Hormone (AMH), antral follicle count, body weight, kidney function, and urinary FSH. The aim is to find a minimum FSH level that ensures optimal ovarian response and enables tailored FSH dosages for better outcomes.
Eligibility criteria
Qualifiers
regular 21 - 35 days cycles
BMI between 19 - 30 kg/m2
serum AMH level between 1.5 to 3 ng/ml
a total antral follicle count between 10 to 24
Disqualifiers
hypogonadotropic hypogonadism
history of ovarian surgery
permanent ovarian cysts of any form
older than 39 years
Trial design
Treatments tested in this trial
- Gonal-f (gonadotropin)
Treatment groups
150 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov